A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer
Clinical trial NCT04381130 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04381130
- Sponsor
- Everfront Biotech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2025-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.